| Document |
Document Title |
|
WO/1991/005761A1 |
A method of inhibiting the growth or replication of viruses of the HIV group is disclosed. Also disclosed are compounds useful in the method and pharmaceutical formulations incorporating such compounds. The method involves the use of com...
|
|
WO/1991/003549A1 |
Light activated acyl-enzymes of formula (III) are disclosed. In the compounds of formula (III) ENZ is an enzyme, X is O or S, Y is -NR3R4, -OR5, or -SR5, and Z is a nucleophile; m is 0 to 3 and n is 1 or 2; Y is substituted on the ring a...
|
|
WO/1989/009542A1 |
The invention is directed to azido-substituted octopamine agonists and the radiolabeled derivatives thereof. The invention also relates to pest controlling compositions comprising the azido-substituted octopamine agonists of the inventio...
|
|
WO/1989/004595A2 |
This invention concerns N,N,N',N'-tetramethyl-N''-(3,4-dichlorophenyl)guanidine; 2-[(2,4-dimethylphenyl)imino]-3-methyloxazolidine or N-(3-chloro-4-methylphenyl)-N',N'-dimethylacetamidine and its acid addition and quaternary salts; or a ...
|
|
WO/1985/000366A1 |
Compounds having the formula (I) wherein R1 and R2 are a hydrogen atom, an alkyl group or a hydroxy group, or else R1 and R2 form together a bivalent ethylene or trimethylene radical; R3 is a halogen atom, an alkyl group, an alkoxy group...
|
|
WO/1984/004676A1 |
Polyhydroxybenzo-, polyhydroxyphenylaceto-, and polyhydroxymandelo-substituted amidines, amidates, amidoximes, and hydroxyamidoximes, also polyhydroxybenzonitriles and polyhydroxybenzamides; their syntheses, pharmaceutical formulation an...
|
|
JP7453744B2 |
A compound has a perovskite type crystal structure containing A which is a monovalent cation, B which is a metal ion, and X which is a halide ion as components. The perovskite type crystal structure has a unit cell volume of 0.2000 nm3 o...
|
|
JP7432088B2 |
[Problem] To provide: a tin-based perovskite layer that is highly purified by the removal of a trace amount of Sn4+ present in a system, the tin-based perovskite layer having good photoelectric conversion efficiency due to not being susc...
|
|
JP2024507177A |
The disclosed and claimed invention relates to organometallic amidinate and guanidinate paddlewheel compounds, compositions containing these compounds, and methods of using these compounds as precursors for depositing metal-containing fi...
|
|
JP2024501429A |
Provided herein, in part, are compounds and compositions useful for preparing pralsetinib. Also provided herein are methods of preparing pralsetinib. Also provided herein is an isomer mixture of cis and trans isomers of the compound of f...
|
|
JP7395642B2 |
Compounds useful in inhibiting endo-exonuclease activity and treating cancer have the formula (I):wherein R3 is selected from the group consisting of loweralkyl, oxyalkyl, cycloalkyl, aryl, heteroaryl, heterocycloalkyl, aminoalkyl or a h...
|
|
JP2023551188A |
The present disclosure relates to arylamidines of formula I and their use as fungicides. [Formula 1]
|
|
JP2023550479A |
The present disclosure relates to arylamidines of formula (I) and their use as fungicides. [Formula 1]
|
|
JP2023548809A |
The present disclosure provides a group of amidine analogs and pharmaceutically acceptable salts thereof useful for treating bacterial or fungal infections. Infectious diseases can include those caused by Gram-negative bacteria, Gram-pos...
|
|
JP7239953B2 |
The objective of the present invention is to provide a method for producing a carbonyl halide efficiently to the used halogenated methane. The method for producing a carbonyl halide according to the present invention is characterized in ...
|
|
JP2023508828A |
The present application provides a yttrium/lanthanum group metal precursor compound, a precursor composition for depositing a yttrium/lanthanum group metal-containing film containing the yttrium/lanthanum group metal precursor compound, ...
|
|
JP2023504162A |
Disclosed are disulfide isomerase A4 (PDIA4) inhibitors and their use to inhibit pancreatic β-cell pathogenesis and to treat diabetes. Identify drug candidates that inhibit PDIA4 and have IC50 values from 4 μM to 300 nM. These compound...
|
|
JP7175085B2 |
To provide a method for producing a triazine compound useful as a synthetic intermediate of a charge transport material, conveniently, at low cost and with high selectivity.The present invention provides a method for producing a triazine...
|
|
JP7153734B2 |
Compounds useful in inhibiting endo-exonuclease activity and treating cancer have the formula (I):wherein R3 is selected from the group consisting of loweralkyl, oxyalkyl, cycloalkyl, aryl, heteroaryl, heterocycloalkyl, aminoalkyl or a h...
|
|
JP7142376B2 |
The present invention relates chiral 1, 3-diarylimidazole salt carbene precursors, their methods of preparation, particularly transition metal complexes and their use in chemical synthesis. An air and moisture stable chiral 1, 3-diarylim...
|
|
JP2022533267A |
This disclosure is based on Equation I. [Chemical 1] With respect to arylamidine and its use as a fungicide. One embodiment of the present disclosure comprises applying a compound of formula I or a composition comprising a compound to a ...
|
|
JP2022528315A |
[wrap up] General formula RxMethod for obtaining salt with NI (in the formula, RxN is an organic cation (R)xN+), Where R is the organic substituent R1-, R2-, R3-Represents a substituent (R-) independently selected from the group consisti...
|
|
JP7075891B2 |
A raw material for forming a thin film, comprising a compound represented by General Formula (1) below.(in the formula, Rrepresents a linear or branched alkyl group having 1 to 5 carbon atoms, Rrepresents hydrogen or a linear or branched...
|
|
JP2022517031A |
[Chemical 1] The present invention discloses a 3-substituted phenylamidine compound of the general formula (I). Where R1, R2, R3, R4, R4a, R4b, A and E have the same meaning as defined herein. The present invention further discloses a me...
|
|
JP6974417B2 |
Lanthanide compounds for vapor deposition having ≤50.0 ppm, ≤ 30.0 ppm, or ≤ 10.0 ppm of all halide impurity combined is provided. The purification systems and methods are also provided.
|
|
JP6923534B2 |
This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, compositions containing suc...
|
|
JP6892864B2 |
The present invention addresses the problem of providing an actinic ray-sensitive or radiation-sensitive resin composition having excellent depth of focus (DOF). The present invention addresses the problem of also providing a resist film...
|
|
JP6811000B2 |
The present invention relates phenoxyhalogenphenylamidines of the general formula (I), to a process for their preparation, to the use of the amidines according to the invention for controlling unwanted microorganisms and also to an agroc...
|
|
JP6773938B2 |
The present invention provides a benzoic acid ester compound that has an enteropeptidase inhibitory effect, and use of the compound as a medicament for the treatment or prevention of obesity, diabetes mellitus, or the like.A compound rep...
|
|
JP6736825B2 |
To provide a compound excellent in movement characteristic of electrical charge and transparency.There is provided a compound containing cation and anion, in which the cation contains 3 or more kinds of cations, 10 mol% to 80 mol% of the...
|
|
JP2020114814A |
To provide a novel process for making PI3K inhibitor compound GDC-0032.There is provided a method for preparing PI3K inhibitor GDC-0032 having a structure described above and stereoisomers, geometrical isomers, tautomers and pharmaceutic...
|
|
JP6723817B2 |
To provide a method for efficiently producing (trifluoromethyl)malonic acid ester that is an important compound as a fluorine-containing building block of pharmaceuticals.The (trifluoromethyl)malonic acid ester represented by formula (4)...
|
|
JP2020517608A |
The present invention relates to a 4-substituted phenylamidine derivative of general formula (I), where R5-R6, ArA4, D, G, B, Q and the integer m have the meanings as defined herein. The present invention further relates to methods for t...
|
|
JP6709443B2 |
To provide a compound capable of being manufactured at a low-temperature, having a high exciton binding energy, and excellent in thermal stability.A compound contains cation and anion. The compound has such a structure that: the cation c...
|
|
JP2020515576A |
A method of improving plant safety and / or reducing herbicidal activity while controlling, preventing or controlling phytopathological diseases, and / or a method of reducing plant necrosis, which is a phytopathologist. , A bactericidal...
|
|
JP2020513413A |
The present invention relates to compounds of formula (I), in particular phenylamidines of formula (I), methods of their production, phenylamidines of formula (I) according to the invention for the control of unwanted microorganisms, esp...
|
|
JP6655838B2 |
Provided is a liquid Mg complex. More specifically, provided is a material for forming high quality Mg-based materials such as films. To this end, the material for forming the Mg-based materials includes bis(N,N-diisopropyl-propionamidin...
|
|
JP2020502105A |
Phenoxyphenylamidines and their use as fungicides The present invention relates to a compound of the formula (I), particularly a phenoxyphenyl amidine of the formula (I), a method for producing the same, a phenoxyphenyl amidine of the pr...
|
|
JP2020500850A |
Compound of formula (I)(In the formula, R1, R2, R3, R4, And R5Is provided as defined in claim 1). In addition, the present invention relates to horticultural chemical compositions containing compounds of formula (I), the preparation of t...
|
|
JP2019532106A |
The present invention relates to a 4-substituted phenylamine derivative of general formula (I) with respect to R.1~ R9And A have the meanings as defined in the specification. The present invention is further according to the present inve...
|
|
JP2019532107A |
The present invention relates to a 4-substituted phenylamine derivative of general formula (I) with respect to R.1~ R8And A have the meanings as defined in the specification. The present invention is further according to the present inve...
|
|
JP6598971B2 |
The present invention relates to an organic/inorganic hybrid perovskite having a novel structure which can be used as an absorber of a solar cell, a method for preparing the same, and a solar cell comprising the same. The compound accord...
|
|
JP6598919B2 |
Provided is a novel organometallic complex that has an emission region in the wavelength band of green to blue and high reliability. Provided is an organometallic complex including a structure represented by a general formula (G1). The o...
|
|
JP6587282B2 |
|
|
JP2019125773A |
To provide a light-absorbing material which can increase the conversion efficiency of a perovskite solar cell.A light-absorbing material according to a disclosure hereof has a perovskite crystalline structure, and is represented by the c...
|
|
JP2019089762A |
To provide processes for the preparation of PI3K inhibitor, GDC-0032.The present invention provides GDC-0032 shown below, and intermediates useful for the preparation of the same.SELECTED DRAWING: None
|
|
JP6517884B2 |
The invention provides an optoelectronic device comprising a mixed-anion perovskite, wherein the mixed-anion perovskite comprises two or more different anions selected from halide anions and chalcogenide anions.The invention further prov...
|
|
JP6495392B2 |
To provide a compound having excellent in light absorption characteristics and/or stability; a method for producing the same; and a method for using the same.There is provided a compound containing cations and anions, wherein 10 mol% or ...
|
|
JP6487409B2 |
To provide a compound excellent in uniformity of performance, light absorption properties, and operation stability, a method of producing the same, and a method of using the same.The compound is provided which includes a cation and an an...
|
|
JP2019505492A |
Compound of formula I(In the formula, R1, R2, R3, R4, R5, R6, R7, R8And X are as defined in claim 1). In addition, the present invention relates to horticultural chemical compositions containing compounds of formula (I), the preparation ...
|
